Left Atrial Appendage CLOSURE in Patients With Atrial Fibrillation Compared to Medical Therapy
A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 912 participants.
Also called NCT03463317
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose prevention
- Phase
- Phase 4
- Enrolled
- 912 participants
- Sponsor
- Registry
-
NCT03463317
-
- Other papers using this trial's data
- Left Atrial Appendage Closure or Medical Therapy in Atrial Fibrillation
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- Germany
- Registry status
- Completed
Technical summary
Registry record NCT03463317. Randomized; no masking; primary purpose prevention. Start 2018-02-28 (actual); primary completion 2024-11-30 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Left Atrial Appendage CLOSURE in Patients With Atrial Fibrillation Compared to Medical Therapy
- Acronym
- CLOSURE-AF
- Condition
- Atrial Fibrillation
- Intervention (Device)
- CE-mark approved LAA closure devices
- Intervention (Drug)
- Acetylsalicylic acid
- Intervention (Drug)
- Clopidogrel
- Intervention (Drug)
- Dabigatran
- Intervention (Drug)
- Rivaroxaban
- Intervention (Drug)
- Apixaban
- Intervention (Drug)
- Edoxaban
- Intervention (Drug)
- Phenprocoumon
- Intervention (Drug)
- Warfarin
- Lead sponsor
- Charite University, Berlin, Germany
- Collaborator
- Deutsches Zentrum für Herz-Kreislauf-Forschung (DZHK)
- Collaborator
- Atrial Fibrillation Network
- Collaborator
- Stiftung Institut fuer Herzinfarktforschung
Record details
- Record id
cardio:ct-nct03463317- Content hash
14b00ee304e8089ea74a001ded804e8737b250cb688fca853ba9dcd59d5d5366